Narjust Florez, Co-Director of the Young Lung Cancer Program at Dana-Farber Cancer Institute, shared a newly published study she co-authored with colleagues:
“TKIs in pregnancy for lung cancer: 27 pregnancies, 96.3% live births, 80.8% of mothers responded. They can be considered in selected cases with a multidisciplinary team.
Congrats to Dr. Noseda and Dr. Imbimbo for leading it!”
See important data from the article in the gallery.
Title: Small Molecules Prescribed On- and Off-Label for Thoracic Cancers During Pregnancy: A Combined VigiBase and Systematic Review Analysis
Authors: Roberta Noseda, Giuseppe Salfi, Francesca Bedussi, Manuela Proietto, Martino Pedrani, Daniele Brenna, Luigi Tortola, Giulia Montelatici, Alessandro Santi, Lise Selleret, Patrizia Froesch, Alessandro Ceschi, Emanuel Raschi, Marina Chiara Garassino, Fedro Peccatori, Giovanna Scarfone, Narjust Florez, Jacques Cadranel, Martina Imbimbo
Read the full article in Drugs.
You can also read:
Beyond the Placental Barrier: Chemotherapy During Pregnancy
